Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Blood|June 15, 2011
How I treat Gaucher diseaseAri Zimran
Blood Cells, Molecules & Diseases|September 18, 2017
Recent advances and future challenges in Gaucher diseaseAri Zimran, Jeff Szer
Journal of Inherited Metabolic Disease|November 17, 2007
No justification for very high-dose enzyme therapy for patients with type III Gaucher diseaseAri Zimran, Deborah Elstein
Biologics : Targets & Therapy|September 24, 2009
Review of the safety and efficacy of imiglucerase treatment of Gaucher diseaseDeborah Elstein, Ari Zimran
Pediatric Endocrinology Reviews : PER|October 28, 2014
Management of Gaucher disease: enzyme replacement therapyAri Zimran, Deborah Elstein
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Gaucher disease and the clinical experience with substrate reduction therapyAri Zimran, Deborah Elstein
Blood Cells, Molecules & Diseases|September 18, 2017
Preface to the special issue on Gaucher disease 2017Ari Zimran, Jeff Szer
Expert Review of Endocrinology & Metabolism|February 10, 2019
Safety and efficacy of velaglucerase alfa replacement therapy for patients with type 1 Gaucher diseaseDeborah Elstein, Ari Zimran
American Journal of Hematology|November 5, 2008
Using the International Gaucher Disease Registry data: can we devise a virtuous circle for treated patients?Deborah Elstein, Ari Zimran
Blood Cells, Molecules & Diseases|November 14, 2019
Gaucher disease, myelodysplastic syndrome and ICUSRosa Ruchlemer, Moshe Mittelman, Ari Zimran
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Blood|June 15, 2011
How I treat Gaucher diseaseAri Zimran
Blood Cells, Molecules & Diseases|September 18, 2017
Recent advances and future challenges in Gaucher diseaseAri Zimran, Jeff Szer
Journal of Inherited Metabolic Disease|November 17, 2007
No justification for very high-dose enzyme therapy for patients with type III Gaucher diseaseAri Zimran, Deborah Elstein
Biologics : Targets & Therapy|September 24, 2009
Review of the safety and efficacy of imiglucerase treatment of Gaucher diseaseDeborah Elstein, Ari Zimran
Pediatric Endocrinology Reviews : PER|October 28, 2014
Management of Gaucher disease: enzyme replacement therapyAri Zimran, Deborah Elstein
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Gaucher disease and the clinical experience with substrate reduction therapyAri Zimran, Deborah Elstein
Blood Cells, Molecules & Diseases|September 18, 2017
Preface to the special issue on Gaucher disease 2017Ari Zimran, Jeff Szer
Expert Review of Endocrinology & Metabolism|February 10, 2019
Safety and efficacy of velaglucerase alfa replacement therapy for patients with type 1 Gaucher diseaseDeborah Elstein, Ari Zimran
American Journal of Hematology|November 5, 2008
Using the International Gaucher Disease Registry data: can we devise a virtuous circle for treated patients?Deborah Elstein, Ari Zimran
Blood Cells, Molecules & Diseases|November 14, 2019
Gaucher disease, myelodysplastic syndrome and ICUSRosa Ruchlemer, Moshe Mittelman, Ari Zimran
Pageof 24